Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy, PK and Safety of Testosterone Gel 2% (FE 999303) in Hypogonadal Males
NCT01370369Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- May 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Ferring Pharmaceuticals. Started May 2011; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01370369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370369.